Company press releases

Displaying 251 - 260 of 260 results
Released Company Title Industry Topic
10 May 2022
07:00 CEST 		INNATE PHARMA Innate Pharma Reports First Quarter 2022 Financial Results and Business Update 20103010 Biotechnology Products and services
10 May 2022
07:00 CEST 		INNATE PHARMA Innate Pharma : Information financière du premier trimestre 2022 20103010 Biotechnology Products and services
10 May 2022
06:55 CEST 		INNATE PHARMA Number of Shares and Voting Rights of Innate Pharma as of May 1, 2022 20103010 Biotechnology Share history
10 May 2022
06:55 CEST 		INNATE PHARMA Nouveau nombre d'actions et droits de vote d'Innate Pharma au 1er mai 2022 20103010 Biotechnology Share history
03 May 2022
23:22 CEST 		INNATE PHARMA Innate Pharma Establishes an At-The-Market (“ATM”) Program on Nasdaq 20103010 Biotechnology Share introduction and issues
03 May 2022
23:22 CEST 		INNATE PHARMA Innate Pharma met en place un programme At-The-Market ("ATM") sur le Nasdaq 20103010 Biotechnology Share introduction and issues
03 May 2022
07:00 CEST 		INNATE PHARMA Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update 20103010 Biotechnology Meetings / events
03 May 2022
07:00 CEST 		INNATE PHARMA Innate Pharma organise une conférence téléphonique pour ses résultats au premier trimestre 2022 20103010 Biotechnology Meetings / events
29 Apr 2022
07:00 CEST 		INNATE PHARMA Innate Pharma reçoit d’AstraZeneca un paiement de 50m$ suite au traitement du premier patient dans un essai clinique de Phase 3 avec monalizumab dans le cancer du poumon 20103010 Biotechnology Products and services
29 Apr 2022
07:00 CEST 		INNATE PHARMA Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca 20103010 Biotechnology Products and services